Abbott Experience Highlights Consent Decree Challenges

摘要

Abbott Laboratories' continued difficulties in resolving quality system compliance issues under a consent decree with FDA and the escalating costs associated with the agreement highlight the long-term consequences facing manufacturers subject to injunctive actions.